Advantest (6857.T) — 2024Q4 FY2024 Earnings Call Analysis

Margins Peak at 60%, China Share Bleeds Out

Management wrote down an acquisition to zero while guiding flat revenue in the biggest semiconductor boom in history.

Thesis: Advantest is hitting a structural air pocket. Q4's 60% gross margin was a mix-driven anomaly that management admits is unsustainable. FY25 guidance implies flat constant-currency revenue because the loss of low-end China share (now 22% of sales) is offsetting AI gains. The entire bull case now rests on a 2026 Custom ASIC ramp that management cannot quantify. Until the valuation resets to reflect a no-growth 2025, this is dead money.

Verdict: HOLD — Conviction: MEDIUM

Catalyst: October midterm plan update. Management explicitly delayed updating financial targets until then to get 'more clarity' on the second half.

Key Risk: Inventory divergence. Inventory assets sit at JPY209.7B against a backdrop of 'uncertain' H2 demand. If the hyperscaler digestion phase extends, that inventory becomes a liability.

The Tell: Douglas Lefever on the split between traditional GPU and Custom ASIC revenue: 'I apologize, I can't speculate... Maybe next year, I could give a better idea.' They are selling a 2026 growth story they cannot measure.

Detected Patterns

Friction Level: MODERATE_FRICTION — Management guides for a flat 'transition year' in FY25 while the market prices in linear AI hyper-growth. The 2026 Custom ASIC ramp is the only real lever left.

Report not found

The report data is no longer available. Please return to the archive.